Skip to main content
logo
Rhythm Biosciences Limited (ASX:RHY)
Australia flag Australia · Delayed Price · Currency is AUD
0.0830
-0.0040 (-4.60%)
Sep 11, 2026, 4:10 PM AEST

Rhythm Biosciences Financials Overview

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Revenue
1.741.743.331.743.12.43
Revenue Growth
-2.32%-47.67%90.90%-43.72%27.54%118.98%
Gross Profit
1.331.333.1-1.313.12.43
Operating Income
-5.86-5.86-3.6-6.85-8.44-8.82
Net Income
-5.93-5.93-3.83-6.86-8.22-8.79
Earnings Per Share
-0.02-0.02-0.01-0.03-0.04-0.04
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Investments
3.443.441.480.754.177.6
Total Debt
0.250.251.110.160.080.17
Net Cash (Debt)
3.193.190.370.594.087.43
Net Cash Growth
117.78%751.42%-36.52%-85.54%-44.99%226.62%
Net Cash Per Share
0.010.010.000.000.020.04

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Operating Cash Flow
-5.23-5.23-2.92-6.14-6.96-6.5
Capital Expenditures
-0.03-0.03-0.02-0.08-0.1-0.03
Free Cash Flow
-5.26-5.26-2.94-6.22-7.06-6.52
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Gross Margin
76.29%76.29%93.24%-74.90%100.00%100.00%
Operating Margin
-336.37%-336.37%-108.09%-393.34%-272.60%-363.29%
Pretax Margin
-340.67%-340.67%-115.13%-393.52%-265.44%-362.26%
Profit Margin
-340.67%-340.67%-115.13%-393.52%-265.44%-362.26%
FCF Margin
-302.10%-302.10%-88.52%-356.94%-227.94%-268.74%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PS Ratio
17.6918.504.618.8529.11101.42